Timothy J. Bourdeau
Timothy J. Bourdeau publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #3,999,081 of 7,710,434 ranked researchers
- Rank in United States
- #1,090,920 of 1,627,098
- Works
- 18
- Citations
- 189
- Citations per work
- 10.5
What does Timothy J. Bourdeau research?
Timothy J. Bourdeau's work is mostly in Medicine (94%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1794.0%
- Medicine1794.0%
- Everything else14.0%
- Life Sciences02.0%
- 1Surgery38% of their works
- 2Oncology16% of their works
- 3Pulmonary and Respiratory Medicine16% of their works
- 4Hepatology14% of their works
- 5Gastroenterology10% of their works
- 6Molecular Biology2% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment
- Gastroesophageal reflux and treatments
- Gastrointestinal Bleeding Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Which keywords describe Timothy J. Bourdeau's research?
The keywords of their largest research topics: Neoadjuvant Therapy, Chemotherapy, Epidemiology, Pancreatic Cancer, Surgical Complications, Hepatocellular Carcinoma, Liver Cancer and Biliary Tract Cancer.
- Lung Cancer
- Esophageal Motility Disorders
- CT Screening
- Esophageal Carcinoma
- Endoscopic Stenting
- Biliary Tract Cancer
- Hepatocellular Carcinoma
- Pancreatic Cancer
- Chemotherapy
- Neoadjuvant Therapy
- Epidemiology
- Surgical Complications
- Liver Cancer
- Cholangiocarcinoma
- Esophageal Perforation
- Preoperative Chemoradiotherapy
- Capsule Endoscopy
- Gastroesophageal Reflux Disease
- Upper Gastrointestinal Bleeding
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Neoadjuvant Therapy112 topics
- Chemotherapy102 topics
- Epidemiology103 topics
- Pancreatic Cancer81 topic
- Surgical Complications81 topic
- Hepatocellular Carcinoma61 topic
- Liver Cancer61 topic
- Biliary Tract Cancer51 topic
- Cholangiocarcinoma51 topic
- Endoscopic Stenting41 topic
- Esophageal Perforation41 topic
- Esophageal Carcinoma31 topic
- Preoperative Chemoradiotherapy31 topic
- CT Screening21 topic
- Capsule Endoscopy21 topic
- Esophageal Motility Disorders21 topic
- Gastroesophageal Reflux Disease21 topic
- Lung Cancer21 topic
- Upper Gastrointestinal Bleeding21 topic
Where does Timothy J. Bourdeau work?
Timothy J. Bourdeau's main affiliation in the publication record is AdventHealth Tampa, United States.
How many publications and citations does Timothy J. Bourdeau have?
OpenAlex counts 18 works and 189 citations for Timothy J. Bourdeau, an h-index of 5, ranking #3,999,081 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Timothy J. Bourdeau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.